Post by The George Institute for Global Health

Exciting news from The George Institute for Global Health! Dr Nelson Wang and team have successfully secured a grant from Novo Nordisk Pharmaceuticals to transform care for people living with heart failure and chronic kidney disease. This innovative project will test a new approach—empirical prescribing—using a web-based clinical decision tool to help more patients access life-saving combination therapies, faster. The 12-month study will evaluate the feasibility and impact of this model across Australian hospitals, aiming to improve survival and quality of life for millions. Learn more about this important initiative: https://bit.ly/4e2ATZO